X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


最新的帖子

八月 21, 2018

NASH: The Silent Liver Disease

With the prevalence of Non-alcoholic Steatohepatitis (NASH) rapidly increasing globally, West is working with its pharmaceutical partners to support their development of new injectable treatments for this serious liver condition. However, there are many challenges associated with trying to bring new treatments to market.<br />
Aileen Kinsella

Aileen Kinsella

Director, Segment Marketing, Pharma

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}